Aarti Drugs was founded in 1984 and is part of the USD 900 million Aarti Group of Industries, having a strong R&D Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC), close to production facilities.
With its wholly-owned subsidiary, Pinnacle Life Science Private Limited, the company manufactures Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, and Specialty Chemicals, as well as Formulations. APIs include Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin, and other medications, whereas Specialty Chemicals include Benzene Sulphonyl Chloride, Methyl Nicotinate, and other medications.
Aarti Drugs Share Buyback 2023 Details
|Aarti Drugs Buyback Dates||Coming soon|
|Aarti Drugs Buyback Price||INR 900 per share|
|Market Price on Buyback Approval||INR 508.5 per share|
|Buyback Premium on Market Price||76.99%|
|Buyback Offer Size (Shares)||6,65,000 shares|
|Buyback Offer Size (Amount)||INR 59.85 crore|
|Face Value||INR 10 per share|
|Listing At||NSE, BSE|
Aarti Drugs Buyback Dates (Timeline)
|Board Meeting Intimation for Buyback Proposal||14 July 2023|
|Buyback Approval Date||21 July 2023|
|Public Announcement of Buyback||Coming soon|
|Aarti Drugs Buyback Record Date||4 August 2023|
|Buyback Opening Date||Coming soon|
|Buyback Closing Date||Coming soon|
|Cut-off Date to receive completed tender forms by Registrar||Coming soon|
|Verification Date by the Registrar||Coming soon|
|Return of unaccepted shares by Registrar||Coming soon|
|Extinguishment of accepted shares||Coming soon|
Aarti Drugs Buyback Entitlement Ratio
|Shareholder Category||Entitlement Ratio||Entitlement Ratio (in %)|
|(less than INR 2 Lakh on record date)||–||4.78|
|(for all other Eligible Shareholders)||–||–|
Aarti Drugs Buyback 2023 Documents
- Letter of Offer
- Draft Letter of Offer
- Public Announcement
- Board Approval
- Upcoming Share Buyback
Aarti Drugs Financial Performance
|FY 2021||FY 2022||FY 2023|
Calculation of Investment in Buyback
|Maximum market value of a share holder as on record date||INR 2,00,000|
|Buyback price per share||INR 900|
|Maximum shares for small shareholder (2,00,000/900)||223 shares *|
|Closing price of stock as on 21 July 2023||INR 508.5**|
|Maximum amount invested in buyback (INR 508.5 x 223 shares)||INR 113,395.5|
Aarti Drugs Buyback Acceptance Ratio
|Shares Tendered||Buyback Entitlement||Acceptance ratio||Buyback Profit||Profit in %|
Registrar of Aarti Drugs Buyback 2023
- Coming soon
Manager of Aarti Drugs Buyback 2023
- Coming soon
Process to Participate in Aarti Drugs Buyback
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Aarti Drugs IPO FAQs :
Q1. What are Aarti Drugs buyback dates?
Ans. Aarti Drugs share buyback opens on 2023 and closes on 2023.
Q2. Which type of is Aarti Drugs buyback offer?
Ans. Aarti Drugs buyback is a tender offer.
Q3. What is Aarti Drugs buyback price?
Ans. Aarti Drugs buyback price is INR 900 per share.
Q4. What is Aarti Drugs buyback record date?
Ans. Aarti Drugs buyback record date is 4 August 2023.
Q5. How to participate in Aarti Drugs share buyback?
Ans. Aarti Drugs share buyback will be conducted through the tender process and investors who hold the shares on record date can place orders through their broker.